Nomura Holdings Inc Catalent, Inc. Call Options Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $1.21 Million - $1.28 Million	22,500 New	22,500 $1.27 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $43.7 Million - $49.6 Million	-988,600 Reduced 78.23%	275,100 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $39.5 Million - $83.3 Million	1,238,700 Added 4954.8%	1,263,700 $54.8 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $1.14 Million - $1.86 Million	25,000 New	25,000 $1.64 Million

510

150M

510K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.